The global pharmaceutical market is often considered a stable one, with minor changes occurring over the years. However, this paradigm is rapidly changing: the arrival of new successful biotech companies, the prevalence of expensive and efficacious drugs in oncology, the emerging role of orphan drugs, and finally the Covid-19 pandemic have produced significant changes.

In the two illustrations below, you can appreciate the significant changes which occurred in the last twenty years.

Disclaimers

  • The material in these reviews is from various public open access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred